| Evaluating robustness and sensitivity of the NanoString technologies nCounter platform to enable multiplexed gene expression analysis of clinical samples MH Veldman-Jones, R Brant, C Rooney, C Geh, H Emery, CG Harbron, ... Cancer research 75 (13), 2587-2593, 2015 | 359 | 2015 |
| Production of yellow colour in flowers: redirection of flavonoid biosynthesis in Petunia KM Davies, SJ Bloor, GB Spiller, SC Deroles The Plant Journal 13 (2), 259-266, 1998 | 173 | 1998 |
| AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor, ERBB2 (HER2), and ERBB3: a unique agent for simultaneous ERBB receptor blockade … DM Hickinson, T Klinowska, G Speake, J Vincent, C Trigwell, J Anderton, ... Clinical Cancer Research 16 (4), 1159-1169, 2010 | 139 | 2010 |
| Isolation and antisense suppression of flavonoid 3', 5'-hydroxylasemodifies flower pigments and colour in cyclamen MR Boase, DH Lewis, KM Davies, GB Marshall, D Patel, KE Schwinn, ... BMC plant biology 10, 1-12, 2010 | 110 | 2010 |
| Epidermal growth factor receptor tyrosine kinase inhibitors: similar but different? Y Rukazenkov, G Speake, G Marshall, J Anderton, BR Davies, ... Anti-cancer drugs 20 (10), 856-866, 2009 | 69 | 2009 |
| Circulating biomarkers and resistance to endocrine therapy in metastatic breast cancers: correlative results from AZD9496 oral SERD phase I trial C Paoletti, G Schiavon, EM Dolce, EP Darga, TH Carr, J Geradts, M Hoch, ... Clinical Cancer Research 24 (23), 5860-5872, 2018 | 55 | 2018 |
| Identification of Biomarkers in Human Head and Neck Tumor Cell Lines That Predict For In Vitro Sensitivity to Gefitinib DM Hickinson, GB Marshall, GJ Beran, M Varella‐Garcia, EA Mills, ... Clinical and Translational Science 2 (3), 183-192, 2009 | 54 | 2009 |
| Nucleic acid extraction from formalin-fixed paraffin-embedded cancer cell line samples: a trade off between quantity and quality? C Seiler, A Sharpe, JC Barrett, EA Harrington, EV Jones, GB Marshall BMC clinical pathology 16, 1-13, 2016 | 41 | 2016 |
| Benefits of mTOR kinase targeting in oncology: pre-clinical evidence with AZD8055 G Marshall, Z Howard, J Dry, S Fenton, D Heathcote, N Gray, H Keen, ... Biochemical Society Transactions 39 (2), 456-459, 2011 | 38 | 2011 |
| Vandetanib inhibits both VEGFR-2 and EGFR signalling at clinically relevant drug levels in preclinical models of human cancer SR Brave, R Odedra, NH James, NR Smith, GB Marshall, KL Acheson, ... International journal of oncology 39 (1), 271-278, 2011 | 37 | 2011 |
| Characterisation of aurone biosynthesis in Antirrhinum majus KM Davies, GB Marshall, JM Bradley, KE Schwinn, SJ Bloor, CS Winefield, ... Physiologia Plantarum 128 (4), 593-603, 2006 | 35 | 2006 |
| Long-term expression of the gusA reporter gene in transgenic cyclamen produced from etiolated hypocotyl explants MR Boase, GB Marshall, TA Peters, MJ Bendall Plant cell, tissue and organ culture 70 (1), 27-39, 2002 | 27 | 2002 |
| Spatially resolved deconvolution of the fibrotic niche in lung fibrosis MGJ Michael Eyres, Joseph A. Bell, Elizabeth R. Davies, Aurelie Fabre, Aiman ... Cell Reports 40, 111230, 2022 | 19 | 2022 |
| Method of Predicting the Responsiveness of a Tumour to Erbb Receptor Drugs K Hudson, MC South, G Marshall, M Sam US Patent App. 11/658,159, 2008 | 15 | 2008 |
| Generation of new ornamental varieties through genetic modification of pigment biosynthesis KM Davies, GB Marshall, DH Lewis, CS Winefield, SC Deroles, MR Boase, ... Acta Horticulturae, 435-448, 2003 | 15 | 2003 |
| Serial monitoring of genomic alterations in circulating tumor cells of ER‐positive/HER2‐negative advanced breast cancer: feasibility of precision oncology biomarker detection AK Cani, EM Dolce, EP Darga, K Hu, CJ Liu, J Pierce, K Bradbury, ... Molecular oncology 16 (10), 1969-1985, 2022 | 12 | 2022 |
| The case for an oil-free future J Hamilton, L Stockman, M Brown, G Marshall, G Muttitt, N Rau | 11 | 2004 |
| Differential gene expression between pigmented and non-pigmented cell culture lines of Daucus carota GB Marshall, MAL Smith, CKC Lee, SC Deroles, KM Davies Plant cell, tissue and organ culture 70 (1), 91-97, 2002 | 9 | 2002 |
| Genetic engineering for yellow flower colours. KM Davies, GB Spiller, JM Bradley, CS Winefield, KE Schwinn, CR Martin, ... | 7 | 2001 |
| Profiling HER3/ErbB3 activation in formalin-fixed, paraffin-embedded (FFPE) breast tumor samples that express high and low HER2/ErbB2 levels using proximity-based immunoassays. J Wallweber, A Chenna, R Ravanera, W Huang, D Stathas, G Marshall, ... Cancer Research 73 (8_Supplement), 3029-3029, 2013 | 6 | 2013 |
